Martin Erik Nyeland

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

Espen Jimenez‐Solem, Tonny Studsgaard Petersen, Casper Hansen et al. · Scientific Reports · 2021 · 86 citations · Full text

Computing, Infectious Diseases, Clinical Decision Support +16

Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A.

Liv Øinæs Andersen, Martin Erik Nyeland, Fredrik Nyberg · British Journal of Dermatology · 2019 · 81 citations · Full text

Medicine, Dermatology, Health Sciences +17

Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial

Jonas Salling Quist, Hanne Pedersen, Marie M. Jensen et al. · The Lancet Healthy Longevity · 2024 · 40 citations · Full text

Medicine, Endocrinology, Nutrition +17

Higher self‐reported severity of atopic dermatitis in adults is associated with poorer self‐reported health‐related quality of life in France, Germany, the U.K. and the U.S.A.

Liv Øinæs Andersen, Martin Erik Nyeland, Fredrik Nyberg · British Journal of Dermatology · 2019 · 39 citations · Full text

Medicine, Dermatology, Immunology +13

The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study

Matilde Grupe Frost, Espen Jimenez‐Solem, Mikkel Zöllner Ankarfeldt et al. · Critical Care · 2020 · 27 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +10